Click on image to view larger version.

Figure 2 Flow Diagram of Patients Undergoing PCI

The disposition of patients undergoing percutaneous coronary intervention (PCI) in the OASIS-5 trial in relation to randomized treatment and use of open-label unfractionated heparin (UFH). *8 days was the maximum duration of study drug administration. Mean duration of treatment was 2.5 days. Following protocol amendment.